Phospho-JUN (T231) Antibody

What is the Phospho-JUN (T231) antibody and what does it detect?

Phospho-JUN (T231) antibody specifically recognizes the c-Jun transcription factor only when phosphorylated at threonine 231. This antibody is designed to detect endogenous levels of JUN protein exclusively in its T231-phosphorylated state, allowing researchers to study this specific post-translational modification . The antibody typically targets the region around the phosphorylation site, with the immunogen derived from human c-Jun in the amino acid range of 201-250 . The specificity for the phosphorylated form enables selective detection of activated c-Jun in various experimental contexts.

What applications are Phospho-JUN (T231) antibodies suitable for?

Phospho-JUN (T231) antibodies are compatible with multiple research applications including:

• Immunohistochemistry (IHC): Typically used at dilutions of 1:100-1:300

• Immunofluorescence (IF): Generally used at dilutions of 1:200-1:1000

• Enzyme-Linked Immunosorbent Assay (ELISA): Often used at dilutions around 1:10000

• Western Blotting (WB): While not specifically mentioned for T231, phospho-specific JUN antibodies for other sites typically use dilutions of 1:2000-1:10000

Each application may require optimization of antibody concentration and protocol parameters depending on sample type, preparation method, and detection system.

How should samples be prepared to preserve JUN phosphorylation at T231?

Sample preparation is critical for accurate detection of phosphorylated proteins. When preparing samples for Phospho-JUN (T231) detection:

• Include phosphatase inhibitors in all extraction buffers to prevent dephosphorylation. Commercial phosphatase inhibitor cocktails (e.g., Sigma Aldrich P0044-1 ML and P5726-1 ML) should be added to lysis buffers .

• Keep samples cold (on ice) throughout processing to minimize enzymatic activity.

• Process samples quickly to avoid degradation or dephosphorylation.

• When analyzing tissues, rapid freezing post-collection is essential.

• For cell culture experiments, consider direct lysis in sample buffer to instantly denature proteins and preserve modifications.

For western blot applications specifically, sonication using an ultrasonic device followed by centrifugation at 14,000×g for 10 minutes at 4°C has been demonstrated to be effective for protein extraction while maintaining phosphorylation status .

What are the recommended controls for validating Phospho-JUN (T231) antibody specificity?

When establishing the specificity of Phospho-JUN (T231) antibody, the following controls are recommended:

• Positive control: Samples known to contain phosphorylated JUN at T231, such as cells treated with appropriate stimuli. For phospho-JUN antibodies targeting other sites, UV-treated cells have been used as positive controls .

• Negative control: Untreated or baseline samples with minimal phosphorylation.

• Phosphatase treatment control: Treating a positive sample with lambda phosphatase to remove phosphate groups should eliminate antibody binding.

• Competing peptide control: Pre-incubation of the antibody with the phosphorylated peptide immunogen should block specific binding.

• JUN knockdown or knockout control: Samples from JUN-deficient cells should show no specific signal.

These controls collectively establish that the observed signal is specific to JUN phosphorylated at T231 rather than cross-reactivity with other phospho-proteins or non-specific binding.

What are the optimal fixation and permeabilization methods for immunofluorescence detection of Phospho-JUN (T231)?

For optimal immunofluorescence detection of Phospho-JUN (T231):

• Fixation: 4% paraformaldehyde for 15-20 minutes at room temperature is generally effective for preserving phospho-epitopes while maintaining cellular architecture.

• Permeabilization: 0.1-0.3% Triton X-100 for 5-10 minutes typically provides sufficient access to nuclear targets like c-Jun without excessive extraction.

• Blocking: Use 3-5% BSA or 5-10% normal serum (from the species of the secondary antibody) to reduce non-specific binding.

• Antibody incubation: Overnight incubation at 4°C with Phospho-JUN (T231) antibody at the recommended dilution (typically 1:200-1:1000) .

• Secondary antibody: Incubate for 1-2 hours at room temperature with appropriate fluorophore-conjugated secondary antibody.

Note that methanol fixation should generally be avoided as it can extract phospholipids and may affect phospho-epitope detection. For double immunostaining with other targets, sequential staining protocols may be necessary to avoid cross-reactivity.

How can researchers distinguish between specific Phospho-JUN (T231) signals and background in western blots?

To accurately distinguish specific Phospho-JUN (T231) signals from background in western blots:

• Molecular weight verification: The expected molecular weight of c-Jun is approximately 39-48 kDa, though this may vary depending on the level of phosphorylation and other post-translational modifications .

• Comparison with total JUN: Run parallel blots or strip and reprobe with a total JUN antibody to compare phosphorylated to total protein ratios.

• Positive and negative controls: Include samples with known high and low levels of phosphorylation.

• Treatment with phosphatase: A portion of the positive control sample treated with phosphatase should show reduced or absent signal.

• Loading controls: Use appropriate loading controls (e.g., actin, GAPDH) to normalize protein loading across samples.

• Signal quantification: Use densitometry software to quantify band intensity relative to loading controls and/or total JUN protein.

When analyzing the results, researchers should focus on the specific band at the expected molecular weight and be cautious about interpreting additional bands that may represent non-specific binding or cross-reactivity with other phosphorylated proteins.

What is the significance of T231 phosphorylation of JUN compared to other phosphorylation sites?

c-Jun undergoes multisite phosphorylation that regulates its transcriptional activity, stability, and interaction with other proteins. The T231 phosphorylation site should be considered within this broader context:

• Primary phosphorylation sites: The most studied phosphorylation sites on c-Jun are those in the N-terminal region (Ser63, Ser73, Thr91, and Thr93), which are targeted by JNK and regulate transcriptional activity .

• T231 specificity: Phosphorylation at T231 represents a distinct regulatory mechanism potentially involving different kinases and signaling pathways than the canonical N-terminal sites.

• Functional consequences: While extensive research exists on the effects of N-terminal phosphorylation, the specific functional outcomes of T231 phosphorylation require further investigation.

• Comparative analysis: Researchers often benefit from examining multiple phosphorylation sites simultaneously to understand their interrelationships and hierarchical importance.

Understanding the kinases responsible for T231 phosphorylation and the specific conditions that promote this modification will provide insights into its biological significance relative to other phosphorylation events on c-Jun.

How should researchers normalize and quantify Phospho-JUN (T231) levels across different experimental conditions?

For accurate quantification and normalization of Phospho-JUN (T231) levels:

• Total protein normalization: Normalize phospho-JUN (T231) signal to total JUN protein levels to account for variations in total JUN expression.

• Loading control normalization: Additionally, normalize to housekeeping proteins (e.g., actin, GAPDH) or total protein stains to account for loading differences .

• Relative quantification: Express results as fold change relative to control conditions rather than absolute values.

• Technical replicates: Include multiple technical replicates to account for western blot variability.

• Biological replicates: Perform experiments with at least three biological replicates to account for biological variability.

• Statistical analysis: Apply appropriate statistical tests (e.g., t-test, ANOVA) to determine significance of observed differences.

For immunofluorescence quantification, measure nuclear fluorescence intensity using appropriate imaging software, subtract background signal, and normalize to nuclear area or total nuclear protein (using DAPI or similar nuclear stain).

How can Phospho-JUN (T231) antibodies be used in combination with other techniques to study JUN-dependent signaling networks?

Integrating Phospho-JUN (T231) antibody detection with complementary techniques can provide comprehensive insights into JUN-dependent signaling networks:

• Chromatin Immunoprecipitation (ChIP): Combine with Phospho-JUN (T231) antibodies to identify genomic targets specifically bound by T231-phosphorylated JUN.

• Proximity Ligation Assay (PLA): Use to detect in situ interactions between phosphorylated JUN and potential binding partners.

• Mass Spectrometry: Employ phospho-enrichment followed by mass spectrometry to identify co-occurring phosphorylation events and modified residues.

• CRISPR-Cas9 Gene Editing: Generate T231A or T231D mutants to study the functional consequences of phosphorylation at this site.

• Kinase Inhibitor Screens: Identify the kinases responsible for T231 phosphorylation by screening with small molecule inhibitors.

• Live-Cell Imaging: Combine with fluorescent biosensors to monitor real-time changes in JUN phosphorylation status.

These integrated approaches move beyond simple detection to understand the functional significance of T231 phosphorylation in different cellular contexts and signaling pathways.

What are the methodological considerations for studying the dynamic phosphorylation and dephosphorylation of JUN at T231?

Studying the dynamics of JUN phosphorylation at T231 requires careful experimental design:

• Time-course experiments: Sample collection at multiple time points after stimulus to capture the kinetics of phosphorylation and dephosphorylation.

• Phosphatase inhibitors: Use calyculin A (100 nM) or similar phosphatase inhibitors to block dephosphorylation and capture maximal phosphorylation states .

• Kinase inhibitors: Apply specific kinase inhibitors to identify the enzymes responsible for T231 phosphorylation.

• Pulse-chase experiments: Use metabolic labeling with radioactive phosphate to track the turnover of phosphorylation.

• Single-cell analysis: Employ flow cytometry or immunofluorescence to assess cell-to-cell variability in phosphorylation dynamics .

• Mathematical modeling: Develop kinetic models to understand the rate constants of phosphorylation and dephosphorylation processes.

When studying phosphorylation dynamics, it's essential to consider the rapid nature of these modifications, which may occur on a timescale of minutes to hours, necessitating appropriate experimental design with sufficient temporal resolution.

How can researchers differentiate between the direct and indirect effects of signaling pathways on JUN T231 phosphorylation?

Distinguishing direct from indirect effects on JUN T231 phosphorylation requires sophisticated experimental approaches:

• In vitro kinase assays: Purified kinases and recombinant JUN protein can determine which kinases directly phosphorylate T231.

• Pharmacological inhibitors with temporal resolution: Apply inhibitors at different time points to determine the sequence of signaling events.

• Genetic approaches: Use CRISPR-Cas9 to generate knockout or knock-in cell lines for suspected kinases or upstream regulators.

• Phosphomimetic and phosphodeficient mutants: Create T231D (phosphomimetic) or T231A (phosphodeficient) JUN mutants to assess functional consequences.

• Computational network analysis: Model signaling networks to predict direct versus indirect regulatory relationships.

• Cell-free reconstitution systems: Reconstruct signaling pathways in vitro to demonstrate direct phosphorylation events.

These approaches collectively help researchers map the signaling hierarchy and distinguish primary phosphorylation events from secondary or compensatory responses in the complex network of JUN regulation.

What are common issues encountered when using Phospho-JUN (T231) antibodies and how can they be resolved?

Common challenges with Phospho-JUN (T231) antibodies and their solutions include:

For western blotting specifically, researchers may need to optimize transfer conditions and membrane type (PVDF vs. nitrocellulose) for optimal detection of phosphorylated proteins .

How should researchers validate a new lot of Phospho-JUN (T231) antibody before use in critical experiments?

When validating a new lot of Phospho-JUN (T231) antibody:

• Positive control comparison: Test the new lot alongside the previous lot using established positive control samples.

• Dilution series: Perform a titration experiment to determine the optimal working concentration for the new lot.

• Specificity verification: Conduct peptide competition assays with phosphorylated and non-phosphorylated peptides.

• Cross-reactivity assessment: Test against samples with known phosphorylation patterns at different JUN phosphorylation sites.

• Application-specific validation: Validate separately for each intended application (WB, IF, IHC, etc.).

• Signal-to-noise evaluation: Compare specific signal intensity to background across multiple experiments.

Document the validation results thoroughly to establish a reference point for future experiments and to facilitate troubleshooting if issues arise.

What strategies can improve detection sensitivity for low abundance Phospho-JUN (T231) in complex samples?

To enhance detection of low abundance Phospho-JUN (T231):

• Enrichment techniques:

  • Immunoprecipitation with total JUN antibody before analysis with phospho-specific antibody

  • Phospho-protein enrichment using titanium dioxide or immobilized metal affinity chromatography

  • Nuclear fraction isolation to concentrate transcription factors

• Signal amplification methods:

  • Enhanced chemiluminescence (ECL) systems with increased sensitivity

  • Tyramide signal amplification for immunofluorescence applications

  • Quantum dots or other high-sensitivity fluorophores for microscopy

• Sensitivity optimization:

  • Extended antibody incubation times (overnight at 4°C)

  • Optimized blocking conditions to reduce background while preserving specific signal

  • Use of high-sensitivity detection reagents and instruments

• Sample preparation refinements:

  • Inclusion of both phosphatase and protease inhibitor cocktails during extraction

  • Rapid sample processing to minimize dephosphorylation

  • Sonication to ensure complete protein extraction and solubilization

These approaches can significantly improve the detection limit for low abundance phosphorylated proteins in complex biological samples.